Pages that link to "Q46055880"
Jump to navigation
Jump to search
The following pages link to Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. (Q46055880):
Displaying 50 items.
- Diabetes in African Americans (Q28394087) (← links)
- Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study (Q30433331) (← links)
- The uncoupling protein 1 gene, UCP1, is expressed in mammalian islet cells and associated with acute insulin response to glucose in African American families from the IRAS Family Study (Q30445084) (← links)
- Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study (Q33556896) (← links)
- Meaning of upper limit of normal range of post-load 1-h plasma glucose level defined by oral glucose tolerance test in Japanese subjects (Q33607630) (← links)
- Racial and ethnic differences in an estimated measure of insulin resistance among individuals with type 1 diabetes. (Q33683758) (← links)
- Measurement of insulin resistance in vivo (Q33781646) (← links)
- Fat infiltration in muscle: new evidence for familial clustering and associations with diabetes (Q33956234) (← links)
- Genetics of the metabolic syndrome (Q33964734) (← links)
- Rationale, design, methodology and sample characteristics for the family partners for health study: a cluster randomized controlled study (Q34214746) (← links)
- Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. (Q34305172) (← links)
- The dysmetabolic syndrome (Q34328284) (← links)
- Obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent (Q34412926) (← links)
- Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials (Q34419202) (← links)
- comparative study of glucose homeostasis, lipids and lipoproteins, HDL functionality, and cardiometabolic parameters in modestly severely obese African Americans and White Americans with prediabetes: implications for the metabolic paradoxes (Q34996884) (← links)
- Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion (Q35087584) (← links)
- Activation of innate immunity modulates insulin sensitivity, glucose effectiveness and pancreatic β-cell function in both African ancestry and European ancestry healthy humans (Q35137615) (← links)
- Beta cell function and its relation to insulin action in humans: a critical appraisal (Q35754764) (← links)
- β-cell dysfunction in adolescents and adults with newly diagnosed type 2 diabetes mellitus (Q35922968) (← links)
- Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes (Q36129793) (← links)
- OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself (Q36157911) (← links)
- Insulin activation of plasma nonesterified fatty acid uptake in metabolic syndrome (Q36158602) (← links)
- Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents (Q36171119) (← links)
- Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort (Q36560225) (← links)
- Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans (Q36720230) (← links)
- Hyperglycemic clamp-derived disposition index is negatively associated with metabolic syndrome severity in obese subjects (Q36901441) (← links)
- beta-cell function and anti-diabetic pharmacotherapy (Q36947018) (← links)
- Improved Performance of Dynamic Measures of Insulin Response Over Surrogate Indices to Identify Genetic Contributors of Type 2 Diabetes: The GUARDIAN Consortium (Q37025657) (← links)
- Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents (Q37105207) (← links)
- Sagittal abdominal diameter and visceral adiposity: correlates of beta-cell function and dysglycemia in severely obese women (Q37113951) (← links)
- Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women (Q37161799) (← links)
- Pharmacokinetic and pharmacodynamic evaluation of linagliptin in African American patients with type 2 diabetes mellitus. (Q37161909) (← links)
- Incidence and risk factors of insulin resistance syndrome in 20-59 year-old Korean male workers. (Q37223102) (← links)
- The family partners for health study: a cluster randomized controlled trial for child and parent weight management (Q37522366) (← links)
- Special considerations on the management of Latino patients with type 2 diabetes mellitus (Q37850796) (← links)
- Racial Disparities in the Pathogenesis of Type 2 Diabetes and its Subtypes in the African Diaspora: A New Paradigm (Q39015556) (← links)
- Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais (Q39791339) (← links)
- Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens (Q41259514) (← links)
- Insulin Resistance Implications for Type II Diabetes Mellitus and Coronary Heart Disease (Q41579716) (← links)
- Disparities in Cardiovascular Disease and Type 2 Diabetes Risk Factors in Blacks and Whites: Dissecting Racial Paradox of Metabolic Syndrome (Q41608056) (← links)
- Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study (Q43925391) (← links)
- Predictors of insulin sensitivity in Type 2 diabetes mellitus. (Q44051661) (← links)
- Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus (Q44407391) (← links)
- Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians (Q44486601) (← links)
- Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes? (Q44616454) (← links)
- Comparison of oral and intravenous glucose tolerance test derived sensitivity and secretory indices in obese adolescents (Q45777529) (← links)
- Parental History of Type 2 Diabetes Abrogates Ethnic Disparities in Key Glucoregulatory Indices (Q46281157) (← links)
- Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery. (Q46610477) (← links)
- Metabolic consequences of the West African diaspora: lessons from the thrifty gene (Q46808937) (← links)
- Sasang constitutional types can act as a risk factor for insulin resistance (Q47336672) (← links)